|
Drugs: endocrine system
Citations 1-10 of 12 total displayed.
|
Most recent content
(1 Apr 2007):
|
- Therapuetics
Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes
- Donald Smith
Evid Based Med 2007; 12: 53.
[Extract]
[Full text]
|
Past content
(since Sep 2001):
|
- Therapeutics
Review:  glucosidase inhibitors improve glycaemic control but have uncertain effects on patient-important outcomes in type 2 diabetes
- William L Isley
Evid Based Med 2005; 10: 174.
[Extract]
[Full text]
- Therapeutics
Review: ACE inhibitors, but not angiotensin II receptor antagonists, reduce all cause mortality in diabetic nephropathy
- Edgar V Lerma
Evid Based Med 2005; 10: 77.
[Extract]
[Full text]
- Therapeutics
Raloxifene reduced vertebral fractures and breast cancer regardless of prior hormone therapy use in women
- Carolyn Crandall
Evid Based Med 2005; 10: 84.
[Extract]
[Full text]
- Therapeutics
Oestrogen therapy increased stroke risk and decreased hip fracture risk but did not affect coronary heart disease risk in postmenopausal women with prior hysterectomy
- Holly L Thacker
Evid Based Med 2004; 9: 184.
[Extract]
[Full text]
- Therapeutics
Review: metformin does not increase risk of lactic acidosis or increase lactate levels in type 2 diabetes
- James A Kruse
Evid Based Med 2004; 9: 111.
[Extract]
[Full text]
- Therapeutics
Review: metformin used alone or combined with clomifene may improve ovulation rates in the polycystic ovary syndrome
- Kathleen M Hoeger and David S Guzick
Evid Based Med 2004; 9: 85.
[Extract]
[Full text]
- Therapeutics
Training in flexible intensive insulin management improved glycaemic control and quality of life in type 1 diabetes
- Arthur T Evans and Rasa Kazlauskaite
Evid Based Med 2003; 8: 80.
[Extract]
[Full text]
- Therapeutics
Review: metformin does not increase fatal or non-fatal lactic acidosis or blood lactate concentrations in type 2 diabetes mellitus
- Ronald J Sigal
Evid Based Med 2002; 7: 176.
[Extract]
[Full text]
- Therapeutics
A lifestyle intervention or metformin prevented or delayed the onset of type 2 diabetes in people at risk
- Victor M Montori
Evid Based Med 2002; 7: 139.
[Extract]
[Full text]
|
|
